BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 7611285)

  • 1. Teaching about cystic fibrosis carrier screening by using written and video information.
    Clayton EW; Hannig VL; Pfotenhauer JP; Parker RA; Campbell PW; Phillips JA
    Am J Hum Genet; 1995 Jul; 57(1):171-81. PubMed ID: 7611285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cystic fibrosis carrier population screening in the primary care setting.
    Loader S; Caldwell P; Kozyra A; Levenkron JC; Boehm CD; Kazazian HH; Rowley PT
    Am J Hum Genet; 1996 Jul; 59(1):234-47. PubMed ID: 8659530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Communication of carrier status information following universal newborn screening for sickle cell disorders and cystic fibrosis: qualitative study of experience and practice.
    Kai J; Ulph F; Cullinan T; Qureshi N
    Health Technol Assess; 2009 Nov; 13(57):1-82, iii. PubMed ID: 19948087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic counseling and neonatal screening for cystic fibrosis: an assessment of the communication process.
    Ciske DJ; Haavisto A; Laxova A; Rock LZ; Farrell PM
    Pediatrics; 2001 Apr; 107(4):699-705. PubMed ID: 11335747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychological impact of population-based carrier testing for cystic fibrosis: 3-year follow-up. UK Cystic Fibrosis Follow-Up Study Group.
    Axworthy D; Brock DJ; Bobrow M; Marteau TM
    Lancet; 1996 May; 347(9013):1443-6. PubMed ID: 8676627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prenatal genetic carrier testing using triple disease screening.
    Eng CM; Schechter C; Robinowitz J; Fulop G; Burgert T; Levy B; Zinberg R; Desnick RJ
    JAMA; 1997 Oct; 278(15):1268-72. PubMed ID: 9333269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cystic fibrosis heterozygote screening in 5,161 pregnant women.
    Witt DR; Schaefer C; Hallam P; Wi S; Blumberg B; Fishbach A; Holtzman J; Kornfeld S; Lee R; Nemzer L; Palmer R
    Am J Hum Genet; 1996 Apr; 58(4):823-35. PubMed ID: 8644747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prenatal screening for cystic fibrosis: psychological effects on carriers and their partners.
    Mennie ME; Compton ME; Gilfillan A; Liston WA; Pullen I; Whyte DA; Brock DJ
    J Med Genet; 1993 Jul; 30(7):543-8. PubMed ID: 8411025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involving consumers in the development of an educational program for cystic fibrosis carrier screening.
    Myers MF; Bernhardt BA; Tambor ES; Holtzman NA
    Am J Hum Genet; 1994 Apr; 54(4):719-26. PubMed ID: 8128971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acceptability of carrier screening for cystic fibrosis during pregnancy in a German population.
    Jung U; Urner U; Grade K; Coutelle C
    Hum Genet; 1994 Jul; 94(1):19-24. PubMed ID: 8034290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Educating patients about cystic fibrosis carrier screening in a primary care setting.
    Bernhardt BA; Chase GA; Faden RR; Geller G; Hofman KJ; Tambor ES; Holtzman NA
    Arch Fam Med; 1996 Jun; 5(6):336-40. PubMed ID: 8640323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Active cascade testing for carriers of cystic fibrosis gene.
    Super M; Schwarz MJ; Malone G; Roberts T; Haworth A; Dermody G
    BMJ; 1994 Jun; 308(6942):1462-7. PubMed ID: 8019278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cystic fibrosis carrier screening in a high-risk population. Participation based on a traditional recruitment process.
    Surh LC; Cappelli M; MacDonald NE; Mettler G; Dales RE
    Arch Pediatr Adolesc Med; 1994 Jun; 148(6):632-7. PubMed ID: 8193692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antenatal screening for carriers of cystic fibrosis: randomised trial of stepwise v couple screening.
    Miedzybrodzka ZH; Hall MH; Mollison J; Templeton A; Russell IT; Dean JC; Kelly KF; Marteau TM; Haites NE
    BMJ; 1995 Feb; 310(6976):353-7. PubMed ID: 7866213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of Parental Understanding of Positive Newborn Screening Results and Carrier Status for Cystic Fibrosis with the use of a Short Educational Video.
    Temme R; Gruber A; Johnson M; Read L; Lu Y; McNamara J
    J Genet Couns; 2015 Jun; 24(3):473-81. PubMed ID: 25236483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of population based screening for carriers of cystic fibrosis.
    Bekker H; Denniss G; Modell M; Bobrow M; Marteau T
    J Med Genet; 1994 May; 31(5):364-8. PubMed ID: 8064812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The uptake and acceptability to patients of cystic fibrosis carrier testing offered in pregnancy by the GP.
    Hartley NE; Scotcher D; Harris H; Williamson P; Wallace A; Craufurd D; Harris R
    J Med Genet; 1997 Jun; 34(6):459-64. PubMed ID: 9192264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carrier screening for cystic fibrosis: a perinatal perspective.
    Demsey SA
    J Perinat Neonatal Nurs; 1999 Sep; 13(2):14-26. PubMed ID: 10818851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A preliminary trial of couple screening for cystic fibrosis: designing an appropriate information leaflet.
    Livingstone J; Axton RA; Mennie M; Gilfillan A; Brock DJ
    Clin Genet; 1993 Feb; 43(2):57-62. PubMed ID: 8448901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prenatal screening for cystic fibrosis carriers: does the method of testing affect the longer-term understanding and reproductive behaviour of women?
    Mennie ME; Axworthy D; Liston WA; Brock DJ
    Prenat Diagn; 1997 Sep; 17(9):853-60. PubMed ID: 9316130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.